Back
Achieve Life Sciences Vs. Atossa Therapeutics Industry Stock Comparison
Buy
54
ACHV
Achieve Life Sciences
Last Price:
4.99
Seasonality Move:
1.15%
Buy
78
ATOS
Atossa Therapeutics
Last Price:
1.57
Seasonality Move:
9.77%
Buy
54
Achieve Life Sciences (ACHV)
is a Buy
Is Achieve Life Sciences a Buy, Sell or Hold?
- The current Achieve Life Sciences [ACHV] share price is $5.00. The Score for ACHV is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ACHV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
78
Atossa Therapeutics (ATOS)
is a Buy
Is Atossa Therapeutics a Buy, Sell or Hold?
- The current Atossa Therapeutics [ATOS] share price is $1.57. The Score for ATOS is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
- ATOS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACHV Stock Price Chart
What is Achieve Life Sciences's stock price today?
-
The Achieve Life Sciences share price today is $5.00
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACHV is experiencing slight buying pressure.
ATOS Stock Price Chart
What is Atossa Therapeutics's stock price today?
-
The Atossa Therapeutics share price today is $1.57
The current trend is moderately bearish and ATOS is experiencing slight selling pressure.
ACHV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 60.24 | Buy |
| Chaikin Money Flow: | 6398 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.44 - 4.86) | Buy |
| Bollinger Bands (100): | (4.21 - 4.75) | Buy |
ATOS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 49.66 | Sell |
| Chaikin Money Flow: | -161386 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.45 - 1.65) | Buy |
| Bollinger Bands (100): | (0.89 - 1.63) | Buy |
ACHV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.87 | Buy |
| 20-day SMA: | 4.69 | Buy |
| 50-day SMA: | 4.58 | Buy |
| 200-day SMA: | 4.53 | Buy |
| 8-day EMA: | 4.92 | Buy |
| 20-day EMA: | 4.75 | Buy |
| 50-day EMA: | 4.61 | Buy |
| 200-day EMA: | 4.67 | Buy |
ATOS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.58 | Sell |
| 20-day SMA: | 1.56 | Buy |
| 50-day SMA: | 1.59 | Sell |
| 200-day SMA: | 1.02 | Buy |
| 8-day EMA: | 1.58 | Sell |
| 20-day EMA: | 1.58 | Sell |
| 50-day EMA: | 1.51 | Buy |
| 200-day EMA: | 1.15 | Buy |
Achieve Life Sciences Earnings Growth & ACHV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.42 per share, and an increase next year of $0.16 per share.
Atossa Therapeutics Earnings Growth & ATOS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.05 per share.
Achieve Life Sciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Atossa Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||